Results 41 to 50 of about 1,254,871 (374)

CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance

open access: yesACS Infectious Diseases, 2023
The emergence of antibiotic-resistant bacterial strains is a source of public health concern across the globe. As the discovery of new conventional antibiotics has stalled significantly over the past decade, there is an urgency to develop novel ...
Arianna Mayorga-Ramos   +4 more
semanticscholar   +1 more source

GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

open access: yesNature Biotechnology, 2014
CRISPR RNA-guided nucleases (RGNs) are widely used genome-editing reagents, but methods to delineate their genome-wide, off-target cleavage activities have been lacking.
S. Tsai   +11 more
semanticscholar   +1 more source

Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice

open access: yesNature Biotechnology, 2023
Antibiotic treatments have detrimental effects on the microbiome and lead to antibiotic resistance. To develop a phage therapy against a diverse range of clinically relevant Escherichia coli , we screened a library of 162 wild-type (WT) phages ...
Y. E. Gençay   +35 more
semanticscholar   +1 more source

Special focus CRISPR-Cas [PDF]

open access: yesRNA Biology, 2013
Six years ago a new sophisticated prokaryotic defense system was identified that was termed CRISPR-Cas (CRISPR, clustered regularly interspaced short palindromic repeats; Cas, CRISPR associated).1-...
openaire   +2 more sources

Genome editing technologies to fight infectious diseases [PDF]

open access: yes, 2017
Genome editing by programmable nucleases represents a promising tool that could be exploited to develop new therapeutic strategies to fight infectious diseases.
Barzon, Luisa   +2 more
core   +1 more source

Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing

open access: yesNature Materials, 2021
Endosomal escape remains a fundamental barrier hindering the advancement of nucleic acid therapeutics. Taking inspiration from natural phospholipids that comprise biological membranes, we report the combinatorial synthesis of multi-tailed ionizable ...
Shuai Liu   +6 more
semanticscholar   +1 more source

Adaptation in CRISPR-Cas Systems [PDF]

open access: yesMolecular Cell, 2016
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins constitute an adaptive immune system in prokaryotes. The system preserves memories of prior infections by integrating short segments of foreign DNA, termed spacers, into the CRISPR array in a process termed adaptation.
Samuel H. Sternberg   +3 more
openaire   +4 more sources

Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

open access: yesNucleic Acids Research, 2013
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) systems in bacteria and archaea use RNA-guided nuclease activity to provide adaptive immunity against invading foreign nucleic acids.
James E. DiCarlo   +5 more
semanticscholar   +1 more source

Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. [PDF]

open access: yesPLoS Genetics, 2013
The immune systems that protect organisms from infectious agents invariably have a cost for the host. In bacteria and archaea CRISPR-Cas loci can serve as adaptive immune systems that protect these microbes from infectiously transmitted DNAs.
Wenyan Jiang   +5 more
doaj   +1 more source

Targeted genome modifications in soybean with CRISPR/Cas9 [PDF]

open access: yes, 2015
Background: The ability to selectively alter genomic DNA sequences in vivo is a powerful tool for basic and applied research. The CRISPR/Cas9 system precisely mutates DNA sequences in a number of organisms.
Jacobs, Thomas   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy